Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CORCEPT THERAPEUTICS INCCORT · Entity 2620 | Chief Business Officer | September 24, 2026 | September 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CORCEPT THERAPEUTICS INC
Report date September 24, 2026 · Filed September 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,056 |
Reported balance
After 2026-09-24 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-24 · Gift · Disposed 17,100 · Balance 14,056 F1: Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 164 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements. |
| Common StockSEC Table I · non-derivative | IndirectCustodial Account for Child | 20,571 |
Reported balance
After 2026-09-24 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-09-24 · Gift · Acquired 5,000 · Balance 20,571 F2: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian. |
| Common StockSEC Table I · non-derivative | IndirectCustodial Account for Child | 20,571 |
Reported balance
After 2026-09-24 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-09-24 · Gift · Acquired 5,000 · Balance 20,571 F3: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian. |
| Common StockSEC Table I · non-derivative | IndirectGary Charles Robb TTE Robb Revocable Trust | 39,716 |
Reported balance
Holding disclosure · report date 2026-09-24 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 39,716 F4: These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 164 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
F2: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
F3: These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
F4: These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 30, 2022 Filed Sep 1, 2022 21:45 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock option (right to buy) · Derivative | 167,323 | $0.00 Strike: $2.08 | $0.00 |
DisclosureSEC source: 0000899243-22-030201 · doc4.xml · derivative · entry 6 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 167,323 shares Expires 2023-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 21:45 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Tax withholdingCommon Stock | 93,922 | $26.14 | $2,455,121.08 |
DisclosureSEC source: 0000899243-22-030201 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,524 F1 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on August 30, 2022. The options subject to the net exercise were to expire on January 30, 2023. Read SEC document |
| August 30, 2022 Filed Sep 1, 2022 21:45 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 167,323 | $2.08 | $348,031.84 |
DisclosureSEC source: 0000899243-22-030201 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 191,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 06, 2022 Filed Jul 8, 2022 21:20 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock option (right to buy) · Derivative | 32,677 | $0.00 Strike: $2.08 | $0.00 |
DisclosureSEC source: 0000899243-22-025826 · doc4.xml · derivative · entry 6 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,964 Underlying: Common Stock · 32,677 shares Expires 2023-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Fully exercisable. Read SEC document |
| July 06, 2022 Filed Jul 8, 2022 21:20 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 45,000 | $26.00 | $1,170,000.00 |
DisclosureSEC source: 0000899243-22-025826 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,123 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2022. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $26.00 to $26.001. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| July 06, 2022 Filed Jul 8, 2022 21:20 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 32,677 | $2.08 | $67,968.16 |
DisclosureSEC source: 0000899243-22-025826 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,123 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2022 Filed May 19, 2022 21:01 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 6,127 | $19.57 | $119,928.06 |
DisclosureSEC source: 0000899243-22-018862 · doc4.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,446 F1 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $19.55 to $19.63. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| May 18, 2022 Filed May 19, 2022 21:01 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 128 | $19.55 | $2,502.40 |
DisclosureSEC source: 0000899243-22-018862 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,573 Read SEC document |
| May 17, 2022 Filed May 19, 2022 21:01 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 28,745 | $19.55 | $561,964.75 |
DisclosureSEC source: 0000899243-22-018862 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,701 Read SEC document |
| March 18, 2022 Filed Mar 18, 2022 22:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 4,988 | $24.67 | $123,053.96 |
DisclosureSEC source: 0000899243-22-011614 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,446 F1 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction. Read SEC document |
| March 17, 2022 Filed Mar 18, 2022 22:40 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 7,512 | $24.68 | $185,374.38 |
DisclosureSEC source: 0000899243-22-011614 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,434 F1 · kind: The transaction was made pursuant to a 10b5-1 plan in effect at the time of the transaction. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $24.67 to $24.70. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| February 23, 2022 Filed Feb 15, 2023 00:30 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 1,950 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005068 · doc5.xml · nonDerivative · entry 7 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,943 Read SEC document |
| February 08, 2022 Filed Feb 15, 2023 00:30 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005068 · doc5.xml · nonDerivative · entry 6 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 6,564 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| February 08, 2022 Filed Feb 15, 2023 00:30 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005068 · doc5.xml · nonDerivative · entry 5 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,893 Read SEC document |
| February 08, 2022 Filed Feb 15, 2023 00:30 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005068 · doc5.xml · nonDerivative · entry 4 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 6,564 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| February 08, 2022 Filed Feb 15, 2023 00:30 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005068 · doc5.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,643 Read SEC document |
| February 08, 2022 Filed Feb 15, 2023 00:30 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005068 · doc5.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 6,564 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| February 08, 2022 Filed Feb 15, 2023 00:30 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-005068 · doc5.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,393 Read SEC document |
| February 02, 2022 Filed Feb 12, 2022 00:32 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $19.26 | $0.00 |
DisclosureSEC source: 0000899243-22-005972 · doc4.xml · derivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2032-02-01 F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 2, 2022, so that the total number of shares subject to this option becomes fully vested and exercisable on February 2, 2026. Read SEC document |
| November 18, 2021 Filed Feb 14, 2022 23:26 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 637 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006257 · doc5.xml · nonDerivative · entry 12 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 5,814 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| November 18, 2021 Filed Feb 14, 2022 23:26 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 637 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006257 · doc5.xml · nonDerivative · entry 11 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 5,814 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| November 18, 2021 Filed Feb 14, 2022 23:26 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 637 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006257 · doc5.xml · nonDerivative · entry 10 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 5,814 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| September 15, 2021 Filed Sep 15, 2021 22:13 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 47,853 | $20.49 | $980,742.45 |
DisclosureSEC source: 0000899243-21-036139 · doc4.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,848 F3 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $20.405 to $20.58. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 22:13 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 806 | $20.76 | $16,735.70 |
DisclosureSEC source: 0000899243-21-036139 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,701 F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $20.76 to $20.88. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 22:13 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 6,341 | $20.89 | $132,445.10 |
DisclosureSEC source: 0000899243-21-036139 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,507 F1 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $20.88 to $20.905. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 21:36 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right to Buy) · Derivative | 148,148 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0000899243-21-034772 · doc4.xml · derivative · entry 6 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 148,148 shares Expires 2021-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 21:36 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Tax withholdingCommon Stock | 80,938 | $21.53 | $1,742,595.14 |
DisclosureSEC source: 0000899243-21-034772 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,848 F1 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and tax withholding obligations arising from a net (cashless) exercise of stock options that occurred on August 30, 2021. The options subject to the net exercise expired on September 1, 2021. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 21:36 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 148,148 | $2.70 | $399,999.60 |
DisclosureSEC source: 0000899243-21-034772 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,786 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2021 Filed Feb 14, 2022 23:26 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 700 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006257 · doc5.xml · nonDerivative · entry 9 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,188 Read SEC document |
| August 25, 2021 Filed Feb 14, 2022 23:26 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006257 · doc5.xml · nonDerivative · entry 8 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,888 Read SEC document |
| April 23, 2021 Filed Apr 27, 2021 22:30 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 10,000 | $24.02 | $240,219.00 |
DisclosureSEC source: 0000899243-21-017125 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,638 F1 · kind: These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares. F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $24.00 to $24.065. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| March 24, 2021 Filed Feb 14, 2022 23:26 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 613 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006257 · doc5.xml · nonDerivative · entry 7 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,186 Read SEC document |
| March 24, 2021 Filed Feb 14, 2022 23:26 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 613 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006257 · doc5.xml · nonDerivative · entry 6 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 5,177 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| March 24, 2021 Filed Feb 14, 2022 23:26 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 613 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006257 · doc5.xml · nonDerivative · entry 5 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,799 Read SEC document |
| March 24, 2021 Filed Feb 14, 2022 23:26 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 613 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006257 · doc5.xml · nonDerivative · entry 4 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 5,177 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| March 24, 2021 Filed Feb 14, 2022 23:26 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 613 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006257 · doc5.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,412 Read SEC document |
| March 24, 2021 Filed Feb 14, 2022 23:26 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 613 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006257 · doc5.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 5,177 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| March 24, 2021 Filed Feb 14, 2022 23:26 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 613 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-006257 · doc5.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,025 Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:30 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $25.46 | $0.00 |
DisclosureSEC source: 0000899243-21-009442 · doc4.xml · derivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-02-28 F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of March 1, 2021, so that the total number of shares subject to this option becomes fully vested and exercisable on March 1, 2025, subject to Reporting Person's continued service through each vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 01:15 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 112,100 | $28.22 | $3,163,899.19 |
DisclosureSEC source: 0000899243-21-006772 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,638 F2 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $28.00 to $28.515. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| February 11, 2021 Filed Feb 17, 2021 01:15 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | SaleCommon Stock | 3,400 | $29.78 | $101,248.94 |
DisclosureSEC source: 0000899243-21-006772 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,738 F1 · price: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $29.7826 to $29.7783. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request. Read SEC document |
| February 05, 2021 Filed Feb 8, 2021 22:12 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $29.41 | $0.00 |
DisclosureSEC source: 0000899243-21-005179 · doc4.xml · derivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2031-02-04 F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 5, 2021, so that the total number of shares subject to this option becomes fully vested and exercisable on February 5, 2025. Read SEC document |
| January 22, 2021 Filed Jan 27, 2021 02:35 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionStock Option (Right to Buy) · Derivative | 451,852 | $0.00 Strike: $2.70 | $0.00 |
DisclosureSEC source: 0000899243-21-003422 · doc4.xml · derivative · entry 6 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,148 Underlying: Common Stock · 451,852 shares Expires 2021-09-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Fully exercisable. Read SEC document |
| January 22, 2021 Filed Jan 27, 2021 02:35 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Tax withholdingCommon Stock | 258,739 | $28.06 | $7,260,216.34 |
DisclosureSEC source: 0000899243-21-003422 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,138 F1 · kind: These shares were withheld so the Reporting Person could satisfy the exercise price and tax liability arising from a net (cashless) exercise of stock options that occurred on January 22, 2021. The options subject to the net exercise were to expire on September 1, 2021. Read SEC document |
| January 22, 2021 Filed Jan 27, 2021 02:35 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | Exercise / conversionCommon Stock | 451,852 | $2.70 | $1,220,000.40 |
DisclosureSEC source: 0000899243-21-003422 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 459,877 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 23:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 829 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031312 · doc4.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 4,564 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 23:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 829 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031312 · doc4.xml · nonDerivative · entry 2 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 4,564 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| November 16, 2020 Filed Nov 17, 2020 23:10 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 829 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031312 · doc4.xml · nonDerivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 4,564 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
| February 07, 2020 Filed Feb 11, 2020 22:14 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $13.56 | $0.00 |
DisclosureSEC source: 0000899243-20-004048 · doc4.xml · derivative · entry 1 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2030-02-06 F1 · derivative.exercise_date: Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 7, 2020, so that the total number of shares subject to this option becomes fully vested and exercisable on February 7, 2024. Read SEC document |
| December 17, 2019 Filed Feb 12, 2020 22:17 UTC | CORCEPT THERAPEUTICS INC CORT · Entity 2620 | GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-004320 · doc5.xml · nonDerivative · entry 3 Robb Gary Charles · CIK 0001529655 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Custodial account for child Disclosed balance after: 3,735 F1 · ownership.nature: These shares are held by a child of the reporting person through a custodial account under the Uniform Transfers to Minors Act for which the reporting person is custodian. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.